Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Southwest Oncology Group Trial S9912: intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer.
Smith HO, Moon J, Wilczynski SP, Tiersten AD, Hannigan EV, Robinson WR, Rivkin SE, Anderson GL, Liu PY, Markman M. Smith HO, et al. Gynecol Oncol. 2009 Aug;114(2):206-9. doi: 10.1016/j.ygyno.2009.04.023. Epub 2009 May 23. Gynecol Oncol. 2009. PMID: 19464730 Free PMC article. Clinical Trial.
Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group.
Scudder SA, Liu PY, Wilczynski SP, Smith HO, Jiang C, Hallum AV 3rd, Smith GB, Hannigan EV, Markman M, Alberts DS; Southwest Oncology Group. Scudder SA, et al. Among authors: smith gb, smith ho. Gynecol Oncol. 2005 Mar;96(3):610-5. doi: 10.1016/j.ygyno.2004.11.024. Gynecol Oncol. 2005. PMID: 15721401 Clinical Trial.
Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009.
Tiersten AD, Liu PY, Smith HO, Wilczynski SP, Robinson WR 3rd, Markman M, Alberts DS. Tiersten AD, et al. Among authors: smith ho. Gynecol Oncol. 2009 Mar;112(3):444-9. doi: 10.1016/j.ygyno.2008.10.028. Epub 2009 Jan 12. Gynecol Oncol. 2009. PMID: 19138791 Free PMC article. Clinical Trial.
Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group Study.
Tiersten AD, Moon J, Smith HO, Wilczynski SP, Robinson WR 3rd, Markman M, Alberts DS. Tiersten AD, et al. Among authors: smith ho. Oncology. 2009;77(6):395-9. doi: 10.1159/000279386. Epub 2010 Feb 2. Oncology. 2009. PMID: 20130422 Free PMC article.
Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trial.
Markman M, Glass T, Smith HO, Hatch KD, Weiss GR, Taylor SA, Goodwin JW, Alberts DS. Markman M, et al. Among authors: smith ho. Gynecol Oncol. 2003 Mar;88(3):282-8. doi: 10.1016/s0090-8258(02)00100-2. Gynecol Oncol. 2003. PMID: 12648576 Clinical Trial.
GM-CSF, carboplatin, doxorubicin: a phase I study.
Poplin EA, Alberts DS, Rinehart JJ, Smith HO, Neidhart JA, Hersh EM. Poplin EA, et al. Among authors: smith ho. Cancer Chemother Pharmacol. 1994;33(4):340-6. doi: 10.1007/BF00685910. Cancer Chemother Pharmacol. 1994. PMID: 8281628 Clinical Trial.
222 results